Triazavirin (TZV) Nucleoside Analog/Antimetabolite chemical

Cat.No.S6854

Triazavirin (TZV) is a novel antiviral drug, a nucleoside analogue of nucleic acid that inhibits the synthesis of viral RNA and DNA and replication of genomic fragments. It is active against influenza and a number of other viruses, and is an effective protective agent on the transmission stage of influenza.
Triazavirin (TZV) Nucleoside Analog/Antimetabolite chemical Chemical Structure

Chemical Structure

Molecular Weight: 286.2

Quality Control

Batch: S685401 DMSO]57 mg/mL]false]Water]20 mg/mL]false]Ethanol]Insoluble]false Purity: 99.19%
99.19

Chemical Information, Storage & Stability

Molecular Weight 286.2 Formula

C5H7N6NaO5S

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 928659-17-0 -- Storage of Stock Solutions

Synonyms Riamilovir Smiles CSC1=NN2C(=C(N=NC2=N1)[N+](=O)[O-])[O-].O.O.[Na+]

Solubility

In vitro
Batch:

DMSO : 57 mg/mL (199.16 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 20 mg/mL

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04581915 Terminated
Covid19
Wits Health Consortium (Pty) Ltd|PharmaCentrix (Pty) Ltd|Perinatal HIV Research Unit of the University of the Witswatersrand
September 8 2020 Phase 2|Phase 3

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.